Northstar.
Live chart source: Elation · read-only in Northstar; make clinical chart changes in Elation

Miles Norton

12y, M
DOB 2014-08-10 · ID b19a24fc
No active allergy records returned. Confirm allergy status with the patient or caregiver.
Family and sibling links are not supplied by this Elation connection. Verify relationships in the source chart.
Timeline

Office Visit Note

8/28/2026, 11:00:00 AM· final· Elation Health· source Elation

Office Visit Note

Reason: Office Visit ElationNoteColOne: HPI: Hpi: 1. ADHD [F90.9] * He is taking guanfacine 1.5 mg twice daily and loratadine. * He feels the medication is not working well. * Per mother, he has been sleeping a lot; this was also noted about 6 months ago. * He has been sitting unusually calmly today. * School is starting soon, and there is concern about maintaining steadier symptom control. * He is transitioning from a dual-language track to his community school for 6th grade, which is expected to be an adjustment socially and academically. Hpi: 2. Musculoskeletal * He reports pain at one area after another child tripped him 2 years ago. * He plays soccer and basketball. * He has bowel movements daily. Hpi: 3. Hygiene/diet * He showers most nights but sometimes skips about once weekly. * He uses deodorant/antiperspirant, but not daily. * Diet is being adjusted toward healthier snacks after camps/activities. * He likes salad, does not like French fries, and will drink smoothies with protein powder at times. ElationNoteColOne: Reconciled Medications: Med: * Guanfacine 1.5 mg PO BID Med: * Loratadine ElationNoteColOne: Social History: Social: * Entering 6th grade. Social: * Changing schools from dual-language program to community school. Social: * Participates in soccer and basketball. ElationNoteColOne: Habits: Habits: * Showers nearly nightly; may skip approximately once per week. Habits: * Does not use deodorant daily. Habits: * Working on healthier food choices and snack habits. ElationNoteColTwo: Data: Data: * Reviewed current guanfacine regimen as 1.5 mg twice daily. Data: * Discussed pharmacy concern that tablets are extended release and splitting is suboptimal because it alters release characteristics, though it has been used to achieve current dosing. Data: * Discussed that recent growth may warrant dose escalation. Data: * Reviewed immunization timing: influenza vaccine deferred as it is early in the season; no FluMist available. Data: * Reviewed vaccine schedule: if vaccination is delayed until after age 15, a 3-dose series would be needed. Data: * Sports physical form for school discussed; standard Minnesota sports clearance form to be completed. ElationNoteColTwo: Vitals: Data: - BMI: 20.0 - Height (in): 63.5 - Weight (lbs): 115 ElationNoteColTwo: PE: PE: - General: Pubertal development advanced for age compared with peers. - HENT: Head/hair exam performed. - Abdom: No concerns elicited regarding bowel habits; stools daily. - GU: External genital exam performed. - MSS: Hamstrings tight bilaterally with marked limitation in toe-touch flexibility. Mild tenderness/tension noted at lower extremities near major muscle attachment sites, consistent with growth-related tightness/inflammation. No acute sports-limiting abnormality otherwise discussed. - NS: Calm, seated behavior during visit. - Psych: Interactive and appropriate. ElationNoteColTwo: Assessment & Plan: Assessplan: 1. ADHD [F90.9] Assessplan: 2. Sleepiness/fatigue, likely related to growth/puberty [R53.83] Assessplan: 3. Muscle tightness/poor flexibility with sports participation [M62.89] Assessplan: 4. Pubertal development [Z00.3] Assessplan: 5. Dietary counseling and surveillance [Z71.3] Assessplan: 6. Encounter for immunization counseling [Z71.85] Assessplan: 7. Encounter for examination for participation in sport [Z02.5] ElationNoteColTwo: Follow Up: Followup: Update me in 1-2 weeks after increasing guanfacine. Follow up as needed for medication adjustment and school/sports forms.